Guideline | Drug Name |
---|---|
Simponi, Simponi Aria (golimumab) | Simponi (golimumab) - for subcutaneous use, Simponi Aria (golimumab) - for intravenous use |
Skin Cancer Agents | diclofenac sodium gel 3% |
Skyclarys (omaveloxolone) | Skyclarys (omaveloxolone) |
Skyrizi (risankizumab-rzaa) | Skyrizi IV (risankizumab-rzaa), Skyrizi SC (risankizumab-rzaa) |
Soliris (eculizumab) | Soliris (eculizumab) |
Somatuline Depot (lanreotide) | Lanreotide Injection, Somatuline Depot (lanreotide) |
Somavert (pegvisomant) | Somavert (pegvisomant) |
Sovaldi (sofosbuvir) | Sovaldi (sofosbuvir) |
Spevigo (spesolimab-sbzo) | Spevigo (spesolimab-sbzo) |
Sprycel (dasatinib) | Sprycel (dasatinib) |
Stivarga (regorafenib) | Stivarga (regorafenib) |
Strensiq (asfotase alfa) | Strensiq (asfotase alfa) |
Sucraid (sacrosidase) Oral Solution | Sucraid (sacrosidase) Oral Solution |
Sunosi (solriamfetol) | Sunosi (solriamfetol) |
Sutent (sunitinib) - PA, NF | Sutent (sunitinib) |
Syfovre (pegcetacoplan) | Syfovre (pegcetacoplan) |
Synagis (palivizumab) | Synagis (palivizumab) |
Tabrecta (capmatinib) | Tabrecta (capmatinib) |
Tadalafil | Generic tadalafil |
Tafinlar (dabrafenib) | Tafinlar (dabrafenib) |